课题基金 / 基金详情

REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATION

REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATION
CR2/CD21 表达和激活的调节
批准号:
6288216
负责人:
John Weis
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 2006-01-31

项目摘要

项目成果

John Weis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Applicant's Abstract): The murine CD21/Cr2 gene encodes two proteins demonstrated to be critical in the acquisition of an optimal immune response. Long considered as a phagocytic receptor for Complement-bearing immune complexes, the CD21 pathway now includes signals for B-cell survival and optimal activation, and presentation of native antigen by follicular dendritic cells (FDC) in the germinal centers of the spleen. The expression of murine CD21 is tightly controlled. The proteins are only found on B-cells during a specific stage of differentiation, and are expressed by FDC once these cells have taken up their position within the spleen. This competing application proposes to continue the laboratories analysis of the mechanism of CD21 gene control, and to initiate a new project to dissect the transcriptional pathways that are activated (or inactivated) upon receptor ligation. We propose that the transcription of the CD21 gene is regulated by a set of transcription factors that are present in all lymphocytes and that the lack of expression by T-cells is due to either (1) the presence of a site specific, T-cell specific histone deacetylase, or (2) a site specific, B-cell specific histone acetylase. Published and preliminary data supports DNA accessibility as a primary determinant of CD21 expression in lymphocytes. In vivohomologous recombination experiments are proposed to dissect the role of key regulatory sites in the control of CD21 expression during B-cell differentiation and by FDC. The second major hypothesis to be tested is that B-cell activation via CD21 ligation, plus or minus surface Ig activation, leads to a pathway of transcriptional control that directly influences the state of B-cell differentiation and activation. Using novel gene analysis approaches, we propose to fully characterize these transcriptional pathways for the expression (depression) of known and novel genes. Elucidation of these pathways will lead to means by such activation can be minimized when inappropriate, or accentuated when required for the generation of an optimal B-cell response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
  • 批准号:
    8043909
  • 项目类别:
  • 资助金额:
    $22.58万
  • 财政年份:
    2010
  • 负责人:
    John Weis
  • 依托单位:
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activation
  • 批准号:
    8197848
  • 项目类别:
  • 资助金额:
    $18.69万
  • 财政年份:
    2010
  • 负责人:
    John Weis
  • 依托单位:
Regulation of CR2/CD21 Expression and Activation
  • 批准号:
    7880369
  • 项目类别:
  • 资助金额:
    $1.3万
  • 财政年份:
    2009
  • 负责人:
    John Weis
  • 依托单位:
Role of the Fragilis Proteins in the Immune Response
  • 批准号:
    6894009
  • 项目类别:
  • 资助金额:
    $22.43万
  • 财政年份:
    2004
  • 负责人:
    John Weis
  • 依托单位:
海外基金